Concepedia

Chemoembolization for Hepatocellular Carcinoma: 1-Month Response Determined with Apparent Diffusion Coefficient Is an Independent Predictor of Outcome

Vincent Vandecaveye, Katrijn Michielsen, Frederik De Keyzer, Wim Laleman, Mina Komuta, Katya Op de beeck, Tania Roskams, Frederik Nevens, Chris Verslype, Geert Maleux

Radiology · 2013 · 65 citations · 24 references

DOI

Abstract

The ADC ratio 1 month after TACE was an independent predictor of PFS, which showed stronger association with tumor response than did RECIST, EASL criteria, or mRECIST.

References

24

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet et al. · Journal of Hepatology · 2001 · 4.1K citations

, , +10

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Josep M. Llovet, María Isabel Real, Xavier Montañá et al. · The Lancet · 2002 · 3.5K citations

, , +12

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

Anwar R. Padhani, Guoying Liu, Dow‐Mu Koh et al. · Neoplasia · 2009 · 2K citations · Full text

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Johannes Lämmer, Katarina Malagari, Thomas J. Vogl et al. · CardioVascular and Interventional Radiology · 2009 · 1.5K citations · Full text

Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma

Alejandro Forner, Carmen Ayuso, Marı́a Varela et al. · Cancer · 2008 · 422 citations · Full text